XANDRA
GARCÍA GONZÁLEZ
Profesora asociada de Ciencias de la Salud
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (6)
2022
-
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines
Clinical and Translational Oncology, Vol. 24, Núm. 3, pp. 483-494
2020
-
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease
Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515
2019
2018
-
Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan
Pharmacological Research, Vol. 136, pp. 133-139
2017
-
Identification of new SNPs associated with severe toxicity to capecitabine
Pharmacological Research, Vol. 120, pp. 133-137
-
Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity
Pharmacogenomics, Vol. 18, Núm. 13, pp. 1215-1223